Mainz BioMed is a molecular genetics cancer diagnostic company that manufactures in-vitro diagnostic (IVD) tests. It offers ColoAlert, a colorectal cancer screening stool-based DNA (deoxyribonucleic acid) test, PancAlert, a product candidate for a pancreatic cancer screening test, GenoStrip, a proposed platform technology to detect pathogens or genetic aberrations, and the GenoChips and the HumaSense product line. The company caters to the cancer industry.